Switzerland · Delayed Price · Currency is CHF Addex Therapeutics Statistics
Total Valuation
SWX:ADXN has a market cap or net worth of CHF 6.53 million. The enterprise value is 4.38 million.
| Market Cap | 6.53M |
| Enterprise Value | 4.38M |
Important Dates
The next estimated earnings date is Monday, April 6, 2026.
| Earnings Date | Apr 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SWX:ADXN has 116.57 million shares outstanding. The number of shares has increased by 7.75% in one year.
| Current Share Class | 116.57M |
| Shares Outstanding | 116.57M |
| Shares Change (YoY) | +7.75% |
| Shares Change (QoQ) | +12.09% |
| Owned by Insiders (%) | 17.78% |
| Owned by Institutions (%) | 2.15% |
| Float | 93.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.18 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.72 |
| EV / Sales | 27.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.01 |
| Quick Ratio | 1.91 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -741.25 |
Financial Efficiency
Return on equity (ROE) is -72.84% and return on invested capital (ROIC) is -18.13%.
| Return on Equity (ROE) | -72.84% |
| Return on Assets (ROA) | -15.90% |
| Return on Invested Capital (ROIC) | -18.13% |
| Return on Capital Employed (ROCE) | -40.30% |
| Revenue Per Employee | 79,269 |
| Profits Per Employee | -3.05M |
| Employee Count | 2 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.10 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 49.52 |
| Average Volume (20 Days) | 215,165 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:ADXN had revenue of CHF 158,538 and -6.10 million in losses. Loss per share was -0.06.
| Revenue | 158,538 |
| Gross Profit | -525,653 |
| Operating Income | -2.48M |
| Pretax Income | -6.20M |
| Net Income | -6.10M |
| EBITDA | -2.46M |
| EBIT | -2.48M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 2.19 million in cash and 36,549 in debt, giving a net cash position of 2.15 million or 0.02 per share.
| Cash & Cash Equivalents | 2.19M |
| Total Debt | 36,549 |
| Net Cash | 2.15M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 5.96M |
| Book Value Per Share | 0.05 |
| Working Capital | 1.19M |
Cash Flow
| Operating Cash Flow | -1.58M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,564.90% |
| Pretax Margin | -3,910.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SWX:ADXN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.75% |
| Shareholder Yield | -7.75% |
| Earnings Yield | -93.40% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:ADXN has an Altman Z-Score of -66.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -66.7 |
| Piotroski F-Score | 1 |